TrialEfficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
Trial details
- Registry ID
- NCT06515418
- Phase
- Phase 2
Drug research
Tirzepatide
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as ZEPBOUND
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and OverNCT06515418 | BIOA | Phase 2 | Terminated | 2025-02-06Actual |
| Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObeseNCT06445075 | Scholar Rock, Inc. | Phase 2 | Completed | 2025-03-04Actual |
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Trial details
- Registry ID
- NCT06445075
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |